Works matching DE "GAUCHER'S disease treatment"
Results: 111
Terapia de reemplazo enzimático en una paciente con enfermedad de Gaucher tipo III.
- Published in:
- Acta Pediatrica de Mexico, 2012, v. 33, n. 1, p. 9
- By:
- Publication type:
- Article
A branch retinal artery occlusion in a patient with Gaucher disease.
- Published in:
- 2012
- By:
- Publication type:
- Report
Progressive Supranuclear Palsy-Like Phenotype in a GBA E326K Mutation Carrier.
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 3, p. 444, doi. 10.1002/mdc3.12406
- By:
- Publication type:
- Article
QUALITY OF LIFE OF PATIENTS WITH GAUCHER DISEASE.
- Published in:
- Journal of Nursing UFPE / Revista de Enfermagem UFPE, 2017, v. 11, n. 11, p. 4282, doi. 10.5205/reuol.23542-49901-1-ED.1111201702
- By:
- Publication type:
- Article
Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher...
- Published in:
- 1994
- By:
- Publication type:
- Abstract
From the National Institutes of Health.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Treatment of severe pulmonary hypertension with inhaled iloprost.
- Published in:
- 2003
- By:
- Publication type:
- Case Study
Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cytokines in Gaucher disease: Role in the pathogenesis of bone and pulmonary disease.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2015, v. 16, n. 3, p. 207, doi. 10.1016/j.ejmhg.2015.02.001
- By:
- Publication type:
- Article
PATIENTS WITH GAUCHER DISEASE: RESULTS OF LONG FOLLOW UP.
- Published in:
- Erciyes Medical Journal / Erciyes Tip Dergisi, 2018, v. 40, n. 1, p. S23
- By:
- Publication type:
- Article
EMEA approves OGS drug rejected by FDA.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 9, p. 858, doi. 10.1038/nbt0902-858
- By:
- Publication type:
- Article
Rare health conditions 40: Gaucher’s disease, Pompe disease, Ellis-Van Creveld syndrome, and Duchenne muscular dystrophy.
- Published in:
- British Journal of Healthcare Assistants, 2020, v. 14, n. 10, p. 500, doi. 10.12968/bjha.2020.14.10.500
- By:
- Publication type:
- Article
α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
- Published in:
- Molecular Neurodegeneration, 2018, v. 12, p. 1, doi. 10.1186/s13024-017-0233-5
- By:
- Publication type:
- Article
Echocardiographic assessment in children with Gaucher disease receiving enzyme replacement therapy.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Velaglucerase alfa.
- Published in:
- Australian Prescriber, 2012, v. 35, n. 6, p. 210
- Publication type:
- Article
Overall assessment of patients with type 1 Gaucher disease: a single-centre's experience.
- Published in:
- Journal of Rare Diseases, 2023, v. 2, n. 1, p. 1, doi. 10.1007/s44162-023-00019-6
- By:
- Publication type:
- Article
Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher..
- Published in:
- Annals of Internal Medicine, 1996, v. 125, n. 11, p. 901, doi. 10.7326/0003-4819-125-11-199612010-00005
- By:
- Publication type:
- Article
Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated...
- Published in:
- Annals of Internal Medicine, 1995, v. 122, n. 1, p. 33, doi. 10.7326/0003-4819-122-1-199501010-00005
- By:
- Publication type:
- Article
Gaucher disease.
- Published in:
- International Journal of Child Health & Human Development, 2020, v. 13, n. 2, p. 161
- By:
- Publication type:
- Article
Enfermedad neuropática de Gaucher tratada con terapia de reemplazo a largo plazo.
- Published in:
- Revista Medica del IMSS, 2013, v. 51, n. 3, p. 340
- By:
- Publication type:
- Article
How we manage Gaucher Disease in the era of choices.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 467, doi. 10.1111/bjh.15402
- By:
- Publication type:
- Article
Goal-oriented therapy with miglustat in Gaucher disease.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 1, p. 23, doi. 10.1185/03007990802576518
- By:
- Publication type:
- Article
IMMUNOGLOBULIN HEAVY CHAIN GENE REARRANGEMENTS IN PATIENTS WITH GAUCHER DISEASE.
- Published in:
- Journal of Medical Biochemistry, 2018, v. 37, n. 3, p. 307, doi. 10.1515/jomb-2017-0061
- By:
- Publication type:
- Article
Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems—The taliglucerase alfa story.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0186211
- By:
- Publication type:
- Article
Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0170268
- By:
- Publication type:
- Article
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168135
- By:
- Publication type:
- Article
Glucocerebrosidase is shaking up the synucleinopathies.
- Published in:
- Brain: A Journal of Neurology, 2014, v. 137, n. 5, p. 1304, doi. 10.1093/brain/awu002
- By:
- Publication type:
- Article
Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.
- Published in:
- Brain: A Journal of Neurology, 2012, v. 135, n. 6, p. 1724, doi. 10.1093/brain/aws095
- By:
- Publication type:
- Article
Probing the Inhibitor versus Chaperone Properties of sp2-Iminosugars towards Human β-Glucocerebrosidase: A Picomolar Chaperone for Gaucher Disease.
- Published in:
- Molecules, 2018, v. 23, n. 4, p. 927, doi. 10.3390/molecules23040927
- By:
- Publication type:
- Article
Glycosylation and functionality of recombinant ß-glucocerebrosidase from various production systems.
- Published in:
- Bioscience Reports, 2013, v. 33, n. 5, p. 771, doi. 10.1042/BSR20130081
- By:
- Publication type:
- Article
Four Gaucher disease type II patients with three novel mutations: a single centre experience from Turkey.
- Published in:
- Metabolic Brain Disease, 2018, v. 33, n. 4, p. 1223, doi. 10.1007/s11011-018-0236-0
- By:
- Publication type:
- Article
TYPE 2 GAUCHER DISEASE: ONSET AND EVOLUTION - CASE REPORT.
- Published in:
- Romanian Journal of Pediatrics / Revista Romana de Pediatrie, 2015, v. 64, n. 3, p. 293, doi. 10.37897/rjp.2015.3.12
- By:
- Publication type:
- Article
Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 1, p. 91, doi. 10.1309/AJCPFVSAEGO67NGT
- By:
- Publication type:
- Article
Gaucher disease in Iraqi children (Clinical, diagnostic & therapeutic aspects).
- Published in:
- Pakistan Journal of Medical Sciences, 2016, v. 32, n. 2, p. 319, doi. 10.12669/pjms.322.9316
- By:
- Publication type:
- Article
VPRIV.
- Published in:
- Formulary, 2010, v. 45, n. 4, p. 113
- Publication type:
- Article
Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
- Published in:
- Plant Biotechnology Journal, 2007, v. 5, n. 5, p. 579, doi. 10.1111/j.1467-7652.2007.00263.x
- By:
- Publication type:
- Article
β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01143
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease.
- Published in:
- Pediatric Hematology & Oncology, 2013, v. 30, n. 5, p. 459, doi. 10.3109/08880018.2013.793757
- By:
- Publication type:
- Article
Response to the Letter: Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease.
- Published in:
- Pediatric Hematology & Oncology, 2013, v. 30, n. 5, p. 462, doi. 10.3109/08880018.2013.793758
- By:
- Publication type:
- Article
Miglustat: withdrawal by manufacturer.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 1, p. 21
- Publication type:
- Article
Partial splenic embolization in a child with Gaucher disease, massive splenomegaly and severe thrombocytopenia.
- Published in:
- Pediatric Radiology, 2009, v. 39, n. 9, p. 1006, doi. 10.1007/s00247-009-1303-9
- By:
- Publication type:
- Article
Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy.
- Published in:
- Pediatric Radiology, 2008, v. 38, n. 6, p. 657, doi. 10.1007/s00247-008-0811-3
- By:
- Publication type:
- Article
The Spectrum of Neurological Manifestations Associated with Gaucher Disease.
- Published in:
- Diseases, 2017, v. 5, n. 1, p. 10, doi. 10.3390/diseases5010010
- By:
- Publication type:
- Article
Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128986
- By:
- Publication type:
- Article
Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model.
- Published in:
- PLoS ONE, 2010, v. 5, n. 5, p. 1, doi. 10.1371/journal.pone.0010750
- By:
- Publication type:
- Article
Gaucher's disease oral therapy gets nod from FDA.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 970, doi. 10.1038/nbt1014-970
- By:
- Publication type:
- Article
First plant-made biologic approved.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 6, p. 472, doi. 10.1038/nbt0612-472
- By:
- Publication type:
- Article
Shire's replacement enzymes validate gene activation.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 11, p. 1139, doi. 10.1038/nbt1110-1139a
- By:
- Publication type:
- Article